Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
|
|
ACCENTIA BIOPHARMACEUTICALS INC (ABPI)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Sep-30-12 | Sep-30-11 | Sep-30-10 | Sep-30-09 | Sep-30-08 | Sep-30-07 | Sep-30-06 | Sep-30-05 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 68.3% | 62.9% | 54.2% | 74.2% | 60.6% | 47.7% | 33.5% | 32.7% |
| Gross profit | 31.7% | 37.1% | 45.8% | 25.8% | 39.8% | 52.3% | 66.5% | 67.3% |
| Sales and marketing | 3.3% | 3.3% | 2.2% | 1.3% | 37.8% | 46.0% | 55.8% | 60.2% |
| Research and development | 129.1% | 56.4% | 24.3% | 12.5% | 62.5% | 84.5% | 55.9% | 38.1% |
| General and administrative | 182.9% | 511.8% | 78.8% | 76.5% | 123.6% | 105.7% | 93.0% | 83.7% |
| EBITDA | -183.5% | -516.5% | -48.9% | -60.2% | -157.1% | -206.0% | -134.8% | -114.1% |
| Depreciation | 3.6% | 2.6% | 5.1% | 2.4% | 5.0% | 3.1% | 2.7% | 2.8% |
| EBITA | -187.1% | -519.1% | -54.0% | -62.5% | -161.5% | -209.1% | -137.6% | -116.9% |
| Amortization of intangibles | 2.5% | 11.6% | 5.9% | 2.2% | 7.4% | 5.7% | 8.6% | 9.7% |
| EBIT | -189.6% | -530.7% | -59.9% | -64.7% | -168.2% | -214.8% | -146.1% | -126.7% |
| Pre-tax income | -306.5% | -400.1% | -885.0% | -49.8% | -381.7% | -415.7% | -173.2% | -177.6% |
| Income taxes | 0.0% | -0.1% | -0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -106.6% | -292.0% | -936.0% | -49.9% | 0.0% | 0.0% | 0.0% | 0.0% |
|